Viibryd Side Effects: What the Food Requirement Really Does
Clinically reviewed by Daniel Montville, MD
Reviewed October 21, 2026 · Last updated September 25, 2026
Key Takeaways
- Diarrhea and nausea are Viibryd's most common side effects. In the label's pooled trials, diarrhea affected 26% to 29% of people on Viibryd versus 10% on placebo, and nausea affected 22% to 24% versus 7%.
- The take-with-food rule is about absorption. Taken on an empty stomach, blood levels of vilazodone can drop by about half, which may make it less effective.
- Every trial behind those side effect numbers gave Viibryd with food, so food shouldn't be expected to prevent diarrhea or nausea on its own.
- The label found no dose-related differences in side effects between 20 mg and 40 mg, and in a 1-year study more than 90% of diarrhea, nausea, and headache events were mild or moderate.
If you’ve been told to take Viibryd with food, you probably assumed the food is there to protect your stomach. It’s a reasonable guess, because diarrhea and nausea are its two most common side effects. The prescribing information tells a different story, and knowing it can change how you handle both.
Your gut relies on serotonin, too. Cells in the gut lining release serotonin to trigger the reflexes that move food along and draw fluid into the intestine, and the serotonin transporter clears it away afterward, as a Gastroenterology review of gut serotonin describes. Viibryd (vilazodone) blocks that same transporter and also partially activates serotonin 5-HT1A receptors. Understanding that dual action with some precision explains most of what you feel in the first weeks.
Viibryd builds on a well-established foundation. It shares the serotonin reuptake mechanism of SSRIs, and its label describes four placebo-controlled trials in which it improved depression at 20 mg and 40 mg a day. The results are real, and the science is well established.
But the food rule attached to it is widely misunderstood, and at Siggy we’d rather explain what a rule is for than hand it to you without context. The take-with-food instruction exists because vilazodone is poorly absorbed on an empty stomach, and the diarrhea and nausea rates in the trials were recorded in people who were already taking it with meals. This guide separates those two facts, based on the pharmacokinetic evidence.
What This Page Covers
- What Are the Most Common Viibryd Side Effects?
- Why Viibryd Affects Your Gut
- What the Food Requirement Actually Does
- Viibryd Side Effects at a Glance
- How the Starting Dose Fits In
- Sexual Side Effects and Weight
- When a Side Effect Needs a Call
- How Siggy Thinks About the First Weeks on a New Medication
What Are the Most Common Viibryd Side Effects?
According to the Viibryd prescribing information, the side effects that occurred in at least 5% of people and at least twice as often as with placebo were diarrhea, nausea, vomiting, and insomnia. The label pools four placebo-controlled trials of 8 to 10 weeks, which, like most approval studies, were sponsored by the drug’s manufacturer.
Diarrhea affected 26% of people on 20 mg and 29% on 40 mg, compared with 10% on placebo. Nausea affected 22% and 24%, compared with 7%. Insomnia affected 7% and 6%, compared with 2%.
Few people stopped because of side effects. In those trials, 7.3% of people on Viibryd stopped because of a side effect, compared with 3.5% on placebo, and nausea was the most common reason at 1.4%. The label also reports no dose-related side effects between 20 mg and 40 mg.
Why Viibryd Affects Your Gut
Serotonin in the gut acts as a signal to move and secrete. When a medication slows the clearing of serotonin, those signals can run stronger, which is a likely reason diarrhea and nausea top Viibryd’s side effect list.
The size of Viibryd’s effect is clear in the numbers. A 2012 systematic review of the registration trials calculated a number needed to harm of 6 for both diarrhea and nausea, meaning that for every six people treated, about one more had each symptom than would have on placebo. A 2015 vilazodone meta-analysis of five trials with 2,393 people found the odds of diarrhea were about 3.5 times higher, and nausea about 3.9 times higher, than with placebo.
Severity matters as much as frequency. In a 1-year open-label study of 599 people on 40 mg a day, diarrhea affected 35.7% and nausea 31.6%, but more than 90% of those events were mild or moderate, and only 1.2% and 1.3% stopped because of them. That study had no placebo group, so its rates run higher than the controlled trials.
The trials don’t report exactly how long diarrhea or nausea lasts for most people. If either is still bothering you after the first couple of weeks, or is severe at any point, that’s worth raising with your prescriber rather than waiting it out.
What the Food Requirement Actually Does
The label is specific. Vilazodone’s absolute bioavailability, the share of a dose that reaches your bloodstream, is 72% when it’s taken with food. Taken fasting, total exposure can drop by about 50% and peak levels by about 60%, and the label warns that this can result in inadequate drug concentrations and may reduce effectiveness.
Here’s the part most guides skip. The label states that Viibryd was given with food in its clinical trials, so the 26% to 29% diarrhea rate and the 22% to 24% nausea rate are with-food numbers. Food didn’t prevent those side effects in the people who were studied, and the label doesn’t claim that eating reduces them.
That makes the practical advice simple. Take Viibryd with a meal every day, mainly so you absorb a consistent amount. Consistency also helps your prescriber interpret what you’re feeling, because a dose taken with breakfast one day and on an empty stomach the next can deliver very different amounts of drug.
One more detail from the label is useful to know. If you vomit within 7 hours of taking Viibryd, absorption drops by about 25%, and no replacement dose is needed.
Viibryd Side Effects at a Glance
The table below shows the label’s pooled rates from its placebo-controlled trials, all of which gave Viibryd with food.
| Side Effect | Viibryd 20 mg | Viibryd 40 mg | Placebo |
|---|---|---|---|
| Diarrhea | 26% | 29% | 10% |
| Nausea | 22% | 24% | 7% |
| Dry mouth | 8% | 7% | 5% |
| Insomnia | 7% | 6% | 2% |
| Vomiting | 4% | 5% | 2% |
How the Starting Dose Fits In
Viibryd is started low and stepped up. The label recommends 10 mg once daily with food for 7 days, then 20 mg once daily, with the option to go to 40 mg after at least another 7 days. The recommended target is 20 to 40 mg a day.
That 20 mg option has solid support. In a 10-week trial of 1,133 people, both 20 mg and 40 mg improved depression more than placebo, and vomiting reached the threshold for a common side effect only at 40 mg. For some people, staying at 20 mg can be a reasonable balance, a decision to make with your prescriber.
Titration is built into the label, and it’s a standard way to give your body time to adjust. The trials weren’t designed to measure how much a slower start reduces diarrhea or nausea, so it’s best viewed as sensible practice rather than a guarantee. Our guide to Zoloft side effects in the first two weeks versus long term walks through how early side effects typically compare with later ones on a standard SSRI.
Sexual Side Effects and Weight
Viibryd is sometimes described as easier on sexual function. The evidence is mixed. In a placebo-controlled trial of 481 adults, sexual function questionnaire scores changed about as much on vilazodone as on placebo. The 2012 review, however, found that spontaneously reported sexual side effects were more common with Viibryd, with a number needed to harm of 12.
The label’s pooled data show decreased libido in 3% to 4% of men on Viibryd versus less than 1% on placebo, and erectile dysfunction in 3% of men on 40 mg versus 1% on placebo. In the 10-week trial that also included the SSRI citalopram, sexual function scores improved in every group, with no significant differences between them.
Weight changes were small in the short term. The 481-person trial found no difference from placebo, and in the 1-year study, average weight rose by 1.7 kg among people who stayed in the study.
When a Side Effect Needs a Call
Most side effects are uncomfortable rather than dangerous, but a few need prompt attention. The label flags most of these, and all of them are worth a call to your prescriber or a visit for care:
- Diarrhea or vomiting that keeps you from holding down fluids
- Black or bloody stools, or unusual bleeding or bruising, especially with NSAIDs, aspirin, or blood thinners
- Agitation, fever, sweating, muscle twitching, or confusion, which can signal serotonin syndrome
- Racing thoughts, reckless behavior, or much less need for sleep
- Eye pain or sudden changes in vision
Don’t stop suddenly. The label describes discontinuation symptoms such as dizziness, irritability, and electric-shock sensations, and it recommends tapering from 40 mg to 20 mg for 4 days, then 10 mg for 3 days. Like all antidepressants, Viibryd carries a boxed warning about suicidal thoughts and behaviors in children, teens, and young adults. If you have thoughts of harming yourself, call 911 or the 988 Suicide and Crisis Lifeline right away.
How Siggy Thinks About the First Weeks on a New Medication
The first few weeks on a new antidepressant can be the stretch when side effects show up before the benefits do, and that’s when questions pile up. “When side effects start, you’re on your own until the next appointment” is something we hear from patients, and in Viibryd’s trials, nausea was the most common side effect behind stopping.
Viibryd is one of the medications a Siggy prescriber can consider, and whether it fits your plan is a decision a licensed prescriber makes after reviewing your intake. Siggy is designed to follow side effects like nausea and changes in sleep over time, and to offer education in the moment, so a real doctor can see the pattern and adjust with you.
Viibryd’s food rule is about getting a reliable dose into your bloodstream, and its stomach side effects likely come from serotonin acting in your gut. Both are manageable when you know which is which. The tradeoff is that diarrhea and nausea are common enough to plan for, while its sexual side effect advantage hasn’t held up in a head-to-head comparison. For a practical way to keep track of what you’re noticing, see our guide to the side effect categories patients most often forget. Siggy’s free, anonymous intake takes no name, email, or login, and you get a consult summary and a downloadable report you can share with any clinician.
Ready to take control of your mental health? Start your anonymous intake with Siggy and get your plan reviewed by a licensed prescriber.
This article is for education only and isn’t a substitute for personal medical advice. Talk with your own clinician before starting, changing, or stopping any medication.
Mental healthcare should stay with you between appointments.
Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.
Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.
Frequently Asked Questions
What are the most common side effects of Viibryd?
Diarrhea, nausea, vomiting, and trouble sleeping are the most common. In the label's pooled trials, diarrhea affected 26% to 29% of people on Viibryd versus 10% on placebo, and nausea affected 22% to 24% versus 7%.
Why do you have to take Viibryd with food?
Food is needed for absorption. According to the label, vilazodone's bioavailability is 72% with food, and taking it fasting can lower total exposure by about 50% and peak levels by about 60%, which may reduce how well it works.
Does taking Viibryd with food prevent diarrhea?
There's no good evidence that it does. The label ties food to absorption, not to stomach side effects, and the trials that recorded diarrhea in 26% to 29% of people gave Viibryd with food. Tell your prescriber if diarrhea persists.
What happens if you take Viibryd without food?
You may absorb much less of it. The label reports that blood levels can fall by about half when Viibryd is taken fasting, which can lead to inadequate drug levels. If you miss a meal, ask your prescriber or pharmacist how to handle that dose.
Does Viibryd cause fewer sexual side effects than other antidepressants?
The evidence is mixed. Rating scales in the trials showed sexual function changes similar to placebo, but spontaneously reported sexual side effects were more common with Viibryd, and a trial that included citalopram found no significant difference between the groups.
Does Viibryd cause weight gain?
Short-term trials found weight changes similar to placebo. In a 1-year open-label study at 40 mg a day, average weight rose by 1.7 kg among people who stayed on treatment.
Sources
- DailyMed. Viibryd (vilazodone hydrochloride) tablets Prescribing Information. Allergan, Inc. U.S. National Library of Medicine. dailymed.nlm.nih.gov
- Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology. 2007;132(1):397-414. doi:10.1053/j.gastro.2006.11.002
- Citrome L. Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant. International Journal of Clinical Practice. 2012;66(4):356-368. doi:10.1111/j.1742-1241.2011.02885.x
- Zhang XF, Wu L, Wan DJ, et al. Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder. Neuropsychiatric Disease and Treatment. 2015;11:1957-1965. doi:10.2147/NDT.S87968
- Robinson DS, Kajdasz DK, Gallipoli S, et al. A 1-year, open-label study assessing the safety and tolerability of vilazodone in patients with major depressive disorder. Journal of Clinical Psychopharmacology. 2011;31(5):643-646. doi:10.1097/JCP.0b013e31822c6741
- Mathews M, Gommoll C, Chen D, Nunez R, Khan A. Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial. International Clinical Psychopharmacology. 2015;30(2):67-74. doi:10.1097/YIC.0000000000000057
- Khan A, Cutler AJ, Kajdasz DK, et al. A randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder. Journal of Clinical Psychiatry. 2011;72(4):441-447. doi:10.4088/JCP.10m06596